Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Psychedelic tryptamines
5-MeO-MPMI
Другие языки:

    5-MeO-MPMI

    Подписчиков: 0, рейтинг: 0
    5-MeO-MPMI
    5-MeO-N-Me-TMT.svg
    Legal status
    Legal status
    • DE: NpSG (Industrial and scientific use only)
    • UK: Class A
    Identifiers
    • 5-Methoxy-3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-indole
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    ChEMBL
    Chemical and physical data
    Formula C15H20N2O
    Molar mass 244.338 g·mol−1
    3D model (JSmol)
    • CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)OC
    • InChI=1S/C15H20N2O/c1-17-7-3-4-12(17)8-11-10-16-15-6-5-13(18-2)9-14(11)15/h5-6,9-10,12,16H,3-4,7-8H2,1-2H3/t12-/m1/s1 checkY
    • Key:MKEGUJPBCIXABO-GFCCVEGCSA-N checkY
     ☒NcheckY (what is this?)  (verify)

    5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992, and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s. This compound produces psychedelic-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.

    See also


    Новое сообщение